CDKN2A interacting protein N-terminal like pseudogene 3 (CDKN2AIPNLP3)

CDKN2A interacting protein N-terminal like pseudogene 3 (CDKN2AIPNLP3) is annotated as a processed pseudogene in the human genome[2][3]. Pseudogenes are gene sequences that resemble protein-coding genes but cannot encode a functional protein due to mutations or truncations acquired during evolution[1][2]. Most pseudogenes, including CDKN2AIPNLP3, are generally presumed to be nonfunctional relics. A minority of pseudogenes may play a role in regulating parental gene expression at the RNA level (for example, via antisense transcripts, miRNA decoys, or as sources of regulatory lncRNAs), but there is no evidence in the current literature that CDKN2AIPNLP3 has any established biological or pathological function, involvement in disease, or interaction with drugs[2][3][1][4]. **Key context:** - The name and abbreviation conform to standard gene nomenclature for pseudogenes[2][3]. - It is a pseudogene, not a receptor, enzyme, transporter, or other conventional drug target class. - No functional protein product, established pathway, or therapeutic implication is documented for this pseudogene. - While some pseudogenes in general can have regulatory noncoding RNA effects, there is no experimental or clinical evidence showing such a role for CDKN2AIPNLP3 at this time[1][4]. - This entry is likely **not a valid therapeutic target** and may have been included by error or misunderstanding. Given current knowledge, **CDKN2AIPNLP3 should not be treated as a pharmacologically actionable target or molecular biomarker**.

Other names

CDKN2AIPNLP3